Stockscreener 앱 받기
2.10
2.78%
-0.06
시간 외 거래:
2.15
0.05
+2.38%
전일 마감가:
$2.16
열려 있는:
$2.15
하루 거래량:
156.32K
Relative Volume:
0.11
시가총액:
$21.86M
수익:
-
순이익/손실:
$-45.57M
주가수익비율:
-0.3333
EPS:
-6.3
순현금흐름:
$-38.56M
1주 성능:
-24.73%
1개월 성능:
-5.19%
6개월 성능:
+29.63%
1년 성능:
-22.51%
1일 변동 폭
$2.03
$2.185
1주일 범위
$2.03
$2.90
52주 변동 폭
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
명칭
Sab Biotherapeutics Inc
전화
305-845-2813
주소
777 W 41ST ST, MIAMI BEACH
SABS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.10 | 22.49M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 개시 | Leerink Partners | Outperform |
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-10-09 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 개시 | Oppenheimer | Outperform |
| 2021-11-05 | 개시 | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc 주식(SABS)의 최신 뉴스
Is SAB Biotherapeutics Inc. stock bottoming outGold Moves & Free Safe Capital Growth Stock Tips - newser.com
Using data filters to optimize entry into SAB Biotherapeutics Inc.July 2025 Movers & Daily Stock Trend Reports - newser.com
Using R and stats models for SAB Biotherapeutics Inc. Equity Warrant forecasting2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Visual trend scoring systems applied to SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Can technical indicators confirm SAB Biotherapeutics Inc.’s reversalPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Is SAB Biotherapeutics Inc. stock reversal real or fake2025 Market WrapUp & High Accuracy Swing Entry Alerts - newser.com
Will a bounce in SAB Biotherapeutics Inc. Equity Warrant offer an exitTrade Ideas & Daily Stock Momentum Reports - newser.com
Full technical analysis of SAB Biotherapeutics Inc. stockEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Strategies to average down on SAB Biotherapeutics Inc. Equity Warrant2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Will SAB Biotherapeutics Inc. see short term momentumJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Identifying reversal signals in SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Institutional & Technical Confirmation Alerts - newser.com
SAB Biotherapeutics stock maintains Buy rating at H.C. Wainwright on positive diabetes treatment data - Investing.com
How to build a dashboard for SAB Biotherapeutics Inc. stock2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Forecasting SAB Biotherapeutics Inc. Equity Warrant price range with options dataCEO Change & Accurate Intraday Trade Tips - newser.com
Institutional scanner results for SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
SAB Biotherapeutics Inc. Equity Warrant stock prediction for this weekJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
Chardan Capital Reaffirms Buy Rating for SAB Biotherapeutics (NASDAQ:SABS) - Defense World
Is it time to cut losses on SAB Biotherapeutics Inc. Equity Warrant2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
S P Trends: Will SAB Biotherapeutics Inc outperform during market ralliesRate Cut & Stepwise Trade Signal Implementation - خودرو بانک
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Receives Average Rating of “Buy” from Analysts - Defense World
Will SAB Biotherapeutics Inc. bounce back from current supportBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
SABS News Today | Why did SAB Biotherapeutics stock drop today? - MarketBeat
SAB Biotherapeutics (NASDAQ:SABS) Upgraded at Wall Street Zen - Defense World
Q3 Earnings Estimate for SABS Issued By Leerink Partnrs - Defense World
Will SAB Biotherapeutics Inc. Equity Warrant stock go up soonJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Does SAB Biotherapeutics Inc. qualify in momentum factor screening2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Aug Outlook: Is SAB Biotherapeutics Inc stock a falling knife or bargain buyJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
Aug Reactions: Is SAB Biotherapeutics Inc. Equity Warrant stock undervalued right nowJuly 2025 Levels & AI Powered Market Trend Analysis - خودرو بانک
what data driven models say about sab biotherapeutics inc.’s futureQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com
Is SAB Biotherapeutics Inc. stock poised for growthQuarterly Market Summary & Daily Price Action Insights - newser.com
Intraday pattern recognizer results for SAB Biotherapeutics Inc.Portfolio Growth Summary & Community Verified Trade Alerts - newser.com
Chart based exit strategy for SAB Biotherapeutics Inc. Equity WarrantMarket Movers & Verified Technical Signals - newser.com
Stock Report: Should you buy the dip on Allakos IncJuly 2025 Momentum & Fast Gain Swing Trade Alerts - khodrobank.com
Signal Recap: What’s next for SAB Biotherapeutics Inc. stock2025 Geopolitical Influence & Weekly High Return Stock Opportunities - خودرو بانک
What institutional flow reveals about SAB Biotherapeutics Inc.July 2025 WrapUp & Verified Chart Pattern Signals - newser.com
Whats the beta of Vision Marine Technologies Inc stock2025 Technical Overview & Precise Swing Trade Alerts - khodrobank.com
SAB BIO Highlights Data in Multiple Presentations at EASD - GlobeNewswire
Breakthrough in Type 1 Diabetes: SAB BIO's SAB-142 Shows Sustained Effects Without Lymphodepletion in Phase 1 - Stock Titan
Published on: 2025-09-19 14:28:48 - خودرو بانک
Risk Off: Can CVRx Inc weather a recessionWeekly Trade Review & Daily Volume Surge Signals - khodrobank.com
Aug Swings: What is SAB Biotherapeutics Inc. Equity Warrant’s TAM (Total Addressable Market)July 2025 Review & Weekly Momentum Picks - خودرو بانک
SAB Biotherapeutics Inc. Equity Warrant stock trendline breakdownPortfolio Growth Summary & High Accuracy Trade Alerts - newser.com
What moving averages say about SAB Biotherapeutics Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - newser.com
Published on: 2025-09-19 05:54:36 - خودرو بانک
institutional scanner results for sab biotherapeutics inc. equity warrantPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Regression analysis insights on SAB Biotherapeutics Inc. Equity Warrant performanceMarket Performance Report & High Accuracy Investment Signals - newser.com
Top Moving Stock Now – SAB Biotherapeutics Inc (NASDAQ: SABS) - stocksregister.com
Will breakout in SAB Biotherapeutics Inc. Equity Warrant lead to full recoveryOil Prices & Free Technical Pattern Based Buy Signals - newser.com
SAB Biotherapeutics Presents Phase I Data on SAB-142 Showing Transient Lymphocyte Declines in Healthy Volunteers at 2025 EASD Conference - geneonline.com
Sab Biotherapeutics Inc (SABS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):